Eli Lilly and Company LLY announced that the FDA has granted approval to its drug, Omvoh (mirikizumab), for its second inflammatory bowel disease (IBD) condition, Crohn's disease (“CD”), in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback